Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP3B2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ANKMY1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | RPS6KL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | GRPEL1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | EIF4A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | PHF14 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | PRRC2B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | MAP7D3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |